• A Seibel, W Heinz, C-A Greim, and S Weber.
• Klinik für Anästhesiologie, Intensiv- und Notfallmedizin, Diakonie Klinikum Jung-Stilling, 57074, Siegen, Deutschland. sonoacademy.seibel@gmail.com.
• Anaesthesist. 2021 Feb 1; 70 (2): 146-154.

AbstractProviding medical care to patients suffering from the coronavirus disease 2019 (COVID-19) pandemic is a major challenge for government healthcare systems around the world. The new coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), shows a high organ specificity for the lower respiratory tract. Since there is so far no effective treatment or vaccination against the virus, early diagnostic recognition is of great importance. Due to the specific aspects of the infection, which mainly begins in the peripheral lung parenchyma, lung ultrasonography is suitable as a diagnostic imaging method to identify suspected cases as such in the early stages of the disease. Serial ultrasound examinations on patients with confirmed COVID-19 can promptly detect changes in the affected lung tissue at the bedside. This article summarizes the diagnostic potential of lung ultrasound with respect to screening and therapeutic decision-making in patients with suspected or confirmed SARS-CoV‑2 pneumonia.

15 keywords...

hide…